Literature DB >> 25253511

Fruitful decade for antileishmanial compounds from 2002 to late 2011.

Hidayat Hussain1, Ahmed Al-Harrasi, Ahmed Al-Rawahi, Ivan R Green, Simon Gibbons.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25253511     DOI： 10.1021/cr400552x

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  13 in total

1.  From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Authors:  Emilie Durieu; Eric Prina; Olivier Leclercq; Nassima Oumata; Nicolas Gaboriaud-Kolar; Konstantina Vougogiannopoulou; Nathalie Aulner; Audrey Defontaine; Joo Hwan No; Sandrine Ruchaud; Alexios-Leandros Skaltsounis; Hervé Galons; Gerald F Späth; Laurent Meijer; Najma Rachidi
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 2.  Biologically active quinoline and quinazoline alkaloids part II.

Authors:  Xiao-Fei Shang; Susan L Morris-Natschke; Guan-Zhou Yang; Ying-Qian Liu; Xiao Guo; Xiao-Shan Xu; Masuo Goto; Jun-Cai Li; Ji-Yu Zhang; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2018-02-27       Impact factor: 12.944

3.  An insight into tetrahydro-β-carboline-tetrazole hybrids: synthesis and bioevaluation as potent antileishmanial agents.

Authors:  Pooja Purohit; Anand Kumar Pandey; Deepti Singh; Pradeep Singh Chouhan; Karthik Ramalingam; Mahendra Shukla; Neena Goyal; Jawahar Lal; Prem M S Chauhan
Journal:  Medchemcomm       Date:  2017-07-21       Impact factor: 3.597

Review 4.  Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.

Authors:  Mark C Field; David Horn; Alan H Fairlamb; Michael A J Ferguson; David W Gray; Kevin D Read; Manu De Rycker; Leah S Torrie; Paul G Wyatt; Susan Wyllie; Ian H Gilbert
Journal:  Nat Rev Microbiol       Date:  2017-02-27       Impact factor: 60.633

Review 5.  Peptides to Tackle Leishmaniasis: Current Status and Future Directions.

Authors:  Alberto A Robles-Loaiza; Edgar A Pinos-Tamayo; Bruno Mendes; Cátia Teixeira; Cláudia Alves; Paula Gomes; José R Almeida
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

6.  A Computational Approach Using Bioinformatics to Screening Drug Targets for Leishmania infantum Species.

Authors:  Miguel Angel Chávez-Fumagalli; Mônica Santos Schneider; Daniela Pagliara Lage; Grasiele de Sousa Vieira Tavares; Débora Vasconcelos Costa Mendonça; Thaís Teodoro de Oliveira Santos; Rodrigo Maia Pádua; Ricardo Andrez Machado-de-Ávila; João Paulo Viana Leite; Eduardo Antonio Ferraz Coelho
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-28       Impact factor: 2.629

7.  Antiprotozoal Activity of Triazole Derivatives of Dehydroabietic Acid and Oleanolic Acid.

Authors:  Mariano Walter Pertino; Celeste Vega; Miriam Rolón; Cathia Coronel; Antonieta Rojas de Arias; Guillermo Schmeda-Hirschmann
Journal:  Molecules       Date:  2017-02-28       Impact factor: 4.411

8.  Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance.

Authors:  M Van den Kerkhof; D Mabille; S Hendrickx; P Leprohon; C E Mowbray; S Braillard; M Ouellette; L Maes; G Caljon
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

9.  Novel 5-(nitrothiophene-2-yl)-1,3,4-Thiadiazole Derivatives: Synthesis and Antileishmanial Activity against promastigote stage of Leishmania major.

Authors:  Seyed Esmail Sadat-Ebrahimi; Maryam Mirmohammadi; Zahra Mojallal Tabatabaei; Marjan Azimzadeh Arani; Sogol Jafari-Ashtiani; Mahsa Hashemian; Parham Foroumadi; Azadeh Yahya-Meymandi; Setareh Moghimi; Mohammad Hassan Moshafi; Peiman Norouzi; Susan Kabudanian Ardestani; Alireza Foroumadi
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 10.  Recent Advances in the Discovery of Novel Antiprotozoal Agents.

Authors:  Seong-Min Lee; Min-Sun Kim; Faisal Hayat; Dongyun Shin
Journal:  Molecules       Date:  2019-10-28       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.